We are live on ! Find out more
ACM

Altium Capital Management Portfolio holdings

AUM $42M
This Fund
S&P 500
This Quarter Est. Return
+33.27%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$273M
AUM Growth
+$22.8M
Cap. Flow
+$4.67M
Cap. Flow %
1.71%
Top 10 Hldgs %
26.58%
Holding
166
New
40
Increased
8
Reduced
21
Closed
31

Top Buys

Rank Stock Value
1
BLRX
BioLineRX
BLRX
+$5.92M
2
PLRX icon
Pliant Therapeutics
PLRX
+$4.11M
3
NSTG
NanoString Technologies, Inc.
NSTG
+$3.89M
4
RMD icon
ResMed
RMD
+$3.87M
5
BCAB icon
BioAtla
BCAB
+$3.62M

Top Sells

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$5.32M
2
LNTH icon
Lantheus
LNTH
+$3.48M
3
ESPR
Esperion Therapeutics
ESPR
+$3.45M
4
DXCM icon
DexCom
DXCM
+$3.28M
5
LIVN icon
LivaNova
LIVN
+$3.12M

Sector Composition

Rank Sector Weight
1 Healthcare 79.05%
2 Financials 10.08%
3 Industrials 0.61%
4 Consumer Staples 0.24%
5 Communication Services 0.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTGX icon
151
CALL
Protagonist Therapeutics
PTGX
$9.44B
– –
-365,100
Closed -$2.89M
RZLT icon
152
Rezolute
RZLT
$452M
– –
-411,000
Closed -$1.33M
SAGE
153
DELISTED
Sage Therapeutics
SAGE
– –
-15,000
Closed -$485K
STAA icon
154
STAAR Surgical
STAA
$1.21B
– –
-75,000
Closed -$5.32M
STOK icon
155
Stoke Therapeutics
STOK
$2.11B
– –
-48,000
Closed -$634K
SURGW
156
DELISTED
SurgePays, Inc. Warrant
SURGW
– –
-250,000
Closed -$300K
MORF
157
DELISTED
Morphic Holding, Inc. Common Stock
MORF
– –
-60,000
Closed -$1.3M
SWAV
158
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
– –
-12,000
Closed -$2.29M
LIAN
159
DELISTED
LianBio American Depositary Shares
LIAN
– –
-315,191
Closed -$681K
IMGN
160
DELISTED
Immunogen Inc
IMGN
– –
-280,000
Closed -$1.26M
SONX
161
DELISTED
Sonendo, Inc.
SONX
– –
-37,572
Closed -$65K
RXDX
162
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
– –
-39,000
Closed -$1.1M
GIW
163
DELISTED
GigInternational1, Inc. Common Stock
GIW
– –
-200,000
Closed -$2.01M
LAAA
164
DELISTED
Lakeshore Acquisition I Corp. Ordinary Shares
LAAA
– –
-200,000
Closed -$2M
DBGI
165
Digital Brands Group
DBGI
$8.82M
– –
0
– -$195K
GBT
166
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-85,000
Closed -$2.72M
3 4 5 6
7

Similar funds

TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
ICP
Indus Capital Partners New York $39.7M AUM 53.95% 1-Year Est. Return

Altium Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Altium Capital Management held 166 positions worth $273M, up 9.1% from $250M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Altium Capital Management's Q3 2022 filing shows 40 new, 8 increased, 21 reduced and 31 closed positions. Its largest new stake was BioLineRX: 103,732 shares worth $3.84M. The largest sale was STAAR Surgical, an estimated $5.32M.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, up from 74% a quarter earlier, followed by Financials and Industrials.

  • Altium Capital Management's largest Q3 2022 buy was BioLineRX: 103,732 shares worth $3.84M.
  • Altium Capital Management added most to AngioDynamics in Q3 2022, an estimated $3.41M increase.
  • Altium Capital Management's biggest Q3 2022 reduction was Lantheus, cutting an estimated $3.48M.
  • Altium Capital Management fully exited STAAR Surgical in Q3 2022, selling an estimated $5.32M.
  • Altium Capital Management's ten largest holdings make up 27% of its $273M portfolio in Q3 2022.
  • Altium Capital Management opened 40 new positions and closed 31 in Q3 2022.
  • Altium Capital Management's portfolio value rose 9.1% quarter-over-quarter to $273M.

Based on Altium Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.